An individual partnership under which co-promotion rights for Alesion Ophthalmic Ointment 0.5% were acquired from Santen Pharmaceutical, with joint promotion to be conducted under the sales agreement. The agreement runs through 31 May 2031 and may be extended by mutual agreement.